Economic Impact of Anti-Vascular Endothelial Growth Factor Prior Authorization Process from a Large Electronic Database

About this episode

Dr. Sabin Dang discusses the economic impact of the anti-VEGF prior authorization process based on a large database analysis.

On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Sabin Dang of the Retina Institute in St. Louis discusses his study, “Economic Impact of Anti–Vascular Endothelial Growth Factor Prior Authorization Process From a Large Electronic Database,” published in JVRD. Host Dr. Timothy Murray speaks with Dr. Dang about his team’s large database analysis examining the real-world burden of prior authorization for anti-VEGF injections. The study evaluated approval rates, tr...

People in this episode

Host: Dr. Timothy Murray

Guest: Dr. Sabin Dang

Topics covered

• anti-VEGF
• prior authorization
• health economics
• retina specialists
• database analysis

Keywords

• anti-VEGF
• prior authorization
• economic impact
• retina
• healthcare

Mentioned in this episode

Organizations: Retina Institute, American Society of Retina Specialists, JVRD

Books & works: Economic Impact of Anti–Vascular Endothelial Growth Factor Prior Authorization Process From a Large Electronic Database

More episodes of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum

• Patients at Elevated Risk for Heart Failure Exhibit Reduced Retinal Perfusion · May 22, 2026 · 10 min
• The Impact of Socioeconomic Deprivation on Anti-VEGF Therapy and Ocular Response in DME Patients · May 21, 2026 · 11 min
• Outer Retinal Optical Coherence Tomography Changes Associated with Intraocular Silicone Oil Administration · May 19, 2026 · 11 min
• A Time-Driven Activity-Based Costing Analysis of New Uveitis Patient Visits · April 21, 2026 · 10 min
• Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy · April 15, 2026 · 12 min
• Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan · April 2, 2026 · 13 min